Skip to main content
Notice2023-18009

Statement of Organization, Functions, and Delegations of Authority

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
August 21, 2023

Issuing agencies

Health and Human Services DepartmentFood and Drug Administration

Abstract

The Food and Drug Administration (FDA) is correcting a notice entitled "Statement of Organization, Functions, and Delegations of Authority" that appeared in the Federal Register of August 14, 2023. The document announced amendments to the organization structure for FDA, Center for Devices and Radiological Health (CDRH), Office of Strategic Partnerships and Technology Innovation (OST). Although HHS approved these amendments on June 27, 2023, the Notice inadvertently omitted to include the following language: "FDA will not implement the new organizational structure until after the necessary requirements are completed." This document corrects that error.

Indexed from Federal Register on August 21, 2023.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.